You just read:

Chondrial Therapeutics Secures Up to $22.6 Million in Series A Financing and Licenses Novel Technology for the Treatment of Friedreich's Ataxia

News provided by

Chondrial Therapeutics, Inc.

06 Feb, 2017, 08:02 ET